A pharmaceutical company with limited device prefilled cartridge or device experience approached ZebraSci to support the development of a generic product

PRIMARY CONTAINER & DEVICE SELECTION AND EVALUATION

Timeline

Development activities were completed in 14 months after contract was signed.

Benefit

Company successfully launched their first product in a prefilled pen with no prior pharmaceutical or device experience.

Flat vector illustration showing an exploded view of a blue insulin pen's components alongside the fully assembled device against a pink background.

ZebraSci led the following development activities:

  • Primary container and device selection consultation
  • Container closure integrity testing
  • Primary container & device test method development, functional testing, and documentation
  • Silicone distribution & functional stability testing
  • Final product lot release testing & established market complaint management program
Schedule a consultation and learn more about our capabilities  

Related case studies

Illustration of three people with blood donation equipment, a large blood drop with a cross, and a syringe, on a yellow background with plants and clouds.

New development: E&L studies with AET calculation and toxicological report assessment – 2 temperature conditions

A hand holds a syringe over a bar graph and a rising line graph, symbolizing vaccination impact on statistical trends or data growth.

Design change: E&L studies with AET calculation and toxicological report assessment

A man holding a device with a syringe in the background, illustrating how to hold it.

ZebraSci performs a wide array of functional and CCI methods to support lot release activities on syringes, pens, auto-injectors and vials

Contact Us